Skin Necrosis After Ado-Trastuzumab Emtansine Extravasation
- 1 August 2017
- journal article
- case report
- Published by American Society of Clinical Oncology (ASCO) in Journal of Oncology Practice
- Vol. 13 (8), 555-556
- https://doi.org/10.1200/jop.2016.020198
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Antibody–drug conjugates for cancer therapyThe Lancet Oncology, 2016
- Field Guide to Challenges and Opportunities in Antibody–Drug Conjugates for ChemistsBioconjugate Chemistry, 2015
- Antibody–drug conjugates as novel anti-cancer chemotherapeuticsBioscience Reports, 2015
- Site-specific antibody drug conjugates for cancer therapymAbs, 2013
- Extravasation Injuries in AdultsISRN Dermatology, 2013
- Trastuzumab Emtansine for HER2-Positive Advanced Breast CancerThe New England Journal of Medicine, 2012
- Management of chemotherapy extravasation: ESMO–EONS Clinical Practice GuidelinesAnnals of Oncology, 2012
- MaytansineCancer Treatment Reviews, 1978